Cost and cost-effectiveness analysis of a digital diabetes prevention program: results from the PREDICTS trial.
Transl Behav Med
; 13(7): 501-510, 2023 07 01.
Article
em En
| MEDLINE
| ID: mdl-36809348
Although technology-assisted DPPs have been shown to improve glycemic control and/or weight loss, information is limited on examining relevant costs and the cost-effectiveness of DPPs with the use of remote technologies within a randomized controlled trial design. We evaluated the costs associated with a d-DPP and further examined the cost-effectiveness of the d-DPP with an enhanced usual care condition. The d-DPP was cost-effective in achieving HbA1c reduction and weight loss and offers the prospect of high scalability and sustainability due to its program features and delivery modes, which can be easily translated to other settings.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Diabetes Mellitus Tipo 2
/
Análise de Custo-Efetividade
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article